Prometrium
Controlled Ovarian Hyperstimulation
El Shatby University Hospital for Obstetrics and GynecologyActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Controlled Ovarian Hyperstimulation cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cetrotide El Shatby University Hospital for Obstetrics and Gynecology | D |
Same molecule, other indications
Prometrium is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →